Sign inJoin waitlistJoin the waitlist

Modupe Idowu

Hematology · Ut Physicians

Credentials: · ·

History

Hematology and Medical Oncology
University of Texas Health Science Center at Houston
2008–2011
Internal Medicine
Texas Tech University
2005–2008
Univ of Florida Coll of Med
2001–2005

Research

Elevated sphingosine-1-phosphate promotes sickling and sickle cell disease progression
Journal of Clinical Investigation · 2014 · 113 citations
Hypoxia-mediated impaired erythrocyte Lands' Cycle is pathogenic for sickle cell disease
Scientific Reports · 2016 · 75 citations
Structural and Functional Insight of Sphingosine 1-Phosphate-Mediated Pathogenic Metabolic Reprogramming in Sickle Cell Disease
Scientific Reports · 2017 · 56 citations

HJ
Harinder Juneja
7 papers
Kai Sun
4 papers · 2 as a resident
Kok Chan
3 papers · 3 as a fellow
Lei-Shih Chen
3 papers
WS
Wally Smith
3 papers
Amber Chen-Goodspeed
2 papers · 1 as a resident
Arthi Sridhar
2 papers · 2 as a fellow
Boon San
2 papers · 2 as a resident
Jia Tan
2 papers · 2 as a resident
RB
Robert Brown
2 papers
Yong Yeo
2 papers · 2 as a resident
Abdullah Kutlar
1 paper

Grants

Tailoring Depression Screening for Sickle Cell Disease: A Novel Approach to Mental Health Care.
National Institute on Minority Health and Health Disparities · R21
PI · $445.2K · University of Houston
2026–2028

Clinical trials

A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
Site PI · Recruiting · Phase 3
Novartis Pharmaceuticals
2024–2030
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
Site PI · Recruiting · Phase 1, Phase 2
Novartis Pharmaceuticals
2024–2030